Suchergebnisse - "Touzeau, Cyrille"

PubPharm (13)

1

Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA) : an open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Moreau, P. | Hulin, C. | Perrot, A. | +49

CommentIn: Nat Rev Clin Oncol. 2021 Nov;18(11):676. - PMID 34545220

2

Autologous stem-cell collection following VTD or VRD induction therapy in multiple myeloma : a single-center experience

enthalten in: Bone marrow transplantation | 2021

von Laurent, V. | Fronteau, C. | Antier, C. | +22

3

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA) : a randomised, open-label, phase 3 study

enthalten in: Lancet (London, England) | 2019

von Moreau, P. | Attal, M. | Hulin, C. | +55

CommentIn: Lancet. 2019 Jul 6;394(10192):3-4. - PMID 31171418

4

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting : a single-center retrospective study

enthalten in: Annals of hematology | 2019

von Trudel, S. | Tessoulin, B. | Jullien, M. | +14

5

Daratumumab for the treatment of multiple myeloma

enthalten in: Expert opinion on biological therapy | 2017

von Touzeau, C. | Moreau, P.

6

Triplet combinations in relapsed/refractory myeloma : update on recent phase 3 trials

enthalten in: Expert review of hematology | 2017

von Boudreault, J. | Touzeau, C. | Moreau, P.

7

Pomalidomide in the management of relapsed multiple myeloma

enthalten in: Future oncology (London, England) | 2016

von Touzeau, C. | Moreau, P.

8

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

enthalten in: The New England journal of medicine | 2016

von Moreau, P. | Masszi, T. | Grzasko, N. | +124

CommentIn: Nat Rev Clin Oncol. 2016 Jul;13(7):398. - PMID 27217276

9

Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome : a retrospective case series of eight patients

enthalten in: Leukemia & lymphoma | 2015

von Lestang, E. | Caristan, A. | Néel, A. | +10

10

Multiple myeloma : from front-line to relapsed therapies

enthalten in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting | 2015

von Moreau, P. | Touzeau, C.